Clinical Trials Directory

Trials / Conditions / HER2-positive Solid Tumors

HER2-positive Solid Tumors

10 registered clinical trials studyying HER2-positive Solid Tumors — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of VRN101099 in Patients With HER2-Positive Solid Tumors
NCT06806982
Voronoi, IncPhase 1
Active Not RecruitingELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738
Enliven TherapeuticsPhase 1
RecruitingA Phase 1/1b Study of IAM1363 in HER2 Cancers
NCT06253871
Iambic Therapeutics, IncPhase 1
Active Not RecruitingCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
NCT04660929
Carisma Therapeutics IncPhase 1
CompletedStudy of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors
NCT04521179
Jiangsu Alphamab Biopharmaceuticals Co., LtdPhase 2
UnknownA Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Sol
NCT04460456
Silverback TherapeuticsPhase 1
UnknownJS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors
NCT04280341
Peking UniversityPhase 1
TerminatedA First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Exp
NCT04278144
Bolt Biotherapeutics, Inc.Phase 1 / Phase 2
CompletedA Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors
NCT04501770
Wuhan YZY Biopharma Co., Ltd.Phase 1
UnknownA Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients
NCT04189211
Bio-Thera SolutionsPhase 1